Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth.
about
Oncolytic viruses as immunotherapy: progress and remaining challengesMesenchymal stem cells as delivery vectors for anti-tumor therapyTrial Watch:: Oncolytic viruses for cancer therapyNoninvasive in-vivo tracing and imaging of transplanted stem cells for liver regenerationMeasles to the Rescue: A Review of Oncolytic Measles VirusTrial Watch-Oncolytic viruses and cancer therapyPhase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myelomaParacrine factors of human fetal MSCs inhibit liver cancer growth through reduced activation of IGF-1R/PI3K/Akt signalingBone marrow mesenchymal stem cells suppress metastatic tumor development in mouse by modulating immune systemThe over-expression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinoma.Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy.Stem cell-based therapies for cancer treatment: separating hope from hype.Engineering Stem Cells for Biomedical Applications.Fighting Cancer with Mathematics and Viruses.Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas.Potential and clinical translation of oncolytic measles viruses.Advances in the design and development of oncolytic measles viruses.Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect.Stem cells in cancer therapy: opportunities and challenges.Intranasal delivery of stem cell-based therapies for the treatment of brain malignancies.DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage
P2860
Q26745942-09A9F263-6DF4-4CFF-A563-928E76183EBFQ26861201-98EA14DB-569C-42C0-9DAC-86BA1A48B34BQ27021951-4098E201-D40C-45D3-A672-FD32C692446CQ28071294-D61BD42E-18BC-4B08-A8A9-92C2CF435C67Q28072097-FEAAED64-74B0-453D-A87D-F501D7A38455Q28072347-600716F6-5FC1-40EE-90D6-770E012B2E68Q33441321-CEDE4AEC-7C74-45D8-90D2-73CCD2FFB497Q35399206-3C989881-8CD6-44BB-A9DB-5AC17429A553Q35588431-81A7108E-9304-40E0-9C6B-B9E21490D7DCQ35742449-5F1389B3-C387-4842-BECE-136A6062097EQ37629088-26DB82FF-030A-4FF2-9ECE-43329CCC9C8FQ38245163-D4725BDA-AE06-4D67-86B1-8C64844584ABQ38378499-6A6ECABA-EA4C-4A71-9872-1A64647D7CFEQ38612646-E21B643F-7EDA-4DA7-9859-7041C7EFFD12Q38715077-33235238-F9E8-42BF-A519-2BA2DBF3E1E7Q38764947-F767761A-BF74-475A-A042-1270F4D93A86Q38924566-0FF8D296-3343-4E64-9D9A-42D33C13CFCFQ45324119-E4DC1702-E64B-4D11-877B-41AAEA90FE34Q47142453-669F43C9-439E-4679-93F3-0E45388D0E08Q48117495-F6663CDA-B980-4998-8E51-559092F2752FQ58600219-D7EDAAA9-DAE7-4263-A649-8EDAE8EB8B97
P2860
Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Systemically delivered measles ...... o inhibit liver cancer growth.
@ast
Systemically delivered measles ...... o inhibit liver cancer growth.
@en
type
label
Systemically delivered measles ...... o inhibit liver cancer growth.
@ast
Systemically delivered measles ...... o inhibit liver cancer growth.
@en
prefLabel
Systemically delivered measles ...... o inhibit liver cancer growth.
@ast
Systemically delivered measles ...... o inhibit liver cancer growth.
@en
P2093
P2860
P50
P1476
Systemically delivered measles ...... to inhibit liver cancer growth
@en
P2093
Chang M Guo
Hooi-Tin Ong
London Lucien Ooi
Mark J Federspiel
P2860
P304
P356
10.1016/J.JHEP.2013.07.010
P577
2013-07-16T00:00:00Z